key: cord-1050658-033zdvu4
authors: HILL, Jennifer; ROSEN, Todd
title: Follow-up of asymptomatic positive COVID-19 patients after delivery
date: 2021-10-14
journal: Am J Obstet Gynecol MFM
DOI: 10.1016/j.ajogmf.2021.100515
sha: d02a0a64454fd3ba66dd20a331ed767f94a209df
doc_id: 1050658
cord_uid: 033zdvu4

nan

Thank you for your comments regarding our publication, "Obstetrical outcomes and follow-up for patients with asymptomatic COVID-19 at delivery: A multicenter prospective cohort study."

The author brings up several issues which we wish to address.

First, the positive predictive value of a test depends on the prevalence of the disease in the population that is being tested. COVID-19 is an infectious disease, so minimizing the false negatives is the important test characteristic, in addition to the sensitivity and specificity. Our study used the Cepheid Xpert Xpress rapid COVID-19 test, which has a 99.4% sensitivity, 96.8% specificity, 77% positive predictive value and 100% negative predictive value in our patients. A larger study, testing 27,421 asymptomatic individuals and using 49,542 tests had a positive predictive value of 86.7% (1). Our positive predictive value was slightly lower, but this may be due to the declining prevalence of the disease during the course of our study.

Second, the questions raised regarding the diagnosis of a true infection brings up a question that we had considered when designing our study. Initially, our plan was to obtain viral load data and compare it to the severity of symptoms that our patients experienced. The testing platform that we used, Cepheid Xpert Xpress, had this capability (2) . However, when we analyzed our data and found that the majority of patients who tested positive were asymptomatic, we determined that the addition of viral load data would not strengthen our results. While we understand that an accurate laboratory diagnosis is necessary, we were focusing on the follow-up of these patients.

We acknowledge the limitations of our study and we appreciate the questions that were asked.

Despite the positive predictive value of our test being 77% and the possibility of erroneous diagnoses, we found that most of our patients were asymptomatic positive and did not go on to develop clinically significant infections.

The potential of SARS-CoV-2 antigen-detection tests in the screening of asymptomatic persons

Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Test